According to Drucker the findings, published in December 2023, provided the first demonstration of 'a GLP-1-brain-immune axis that controls inflammation across the body independent of weight loss, even in peripheral organs devoid of GLP1 receptors.' Drucker's team has not yet identified which particular brain cells interact with GLP-1 (AAAS)
This indicates that further research in this area may be warranted
Understanding Semaglutide and Your Digestive System Semaglutide works by slowing down how quickly food leaves your stomach, which helps you feel full longer and reduces your appetite
Human observational or clinical evidence was considered more directly translatable, whereas animal, cell-based, species-specific sperm preservation, and in silico studies were regarded as preclinical or hypothesis-generating evidence
Participants reported their consumption of different animal-sourced foods, and researchers regularly measured the blood levels of a group of chemicals called trimethylamine N-oxide (TMAO) related metabolites